Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Alphabet's Gv Leads Funding In Gene Editing Company Verve Therapeutics - Cna
Venture Capital

Alphabet's Gv Leads Funding In Gene Editing Company Verve Therapeutics - Cna

by channelnewsasia.com posted 2weeks ago 8 views
GV, Alphabet Inc's venture capital arm, led a US$58.5 million investment to launch Verve Therapeutics, a new biotech focused on developing therapies that edit the human genome to treat heart diseases. Gene editing therapies are seen to have huge scope in treating a range of diseases but none are ...

In this article